trial · primary record
XEP527
Schizophrenia
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 36 |
| Primary completion | 2028-03-06 |
| Primary endpoint | Incidence of adverse events (AEs) and serious adverse events (SAEs) |
| Registry ID | NCT07908680 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:54.386Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07908680
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.